How to Export Korean Centella (Cica) Serum to Canada: Health Canada Compliance Guide

Compliance Guide · Canada · Korean Skincare

Selling Korean centella (cica) facial serum in Canada requires more than an effective formula — one missing filing can get your entire shipment turned away at the border. Canadian importers must submit a Cosmetic Notification Form (CNF) to Health Canada within 10 days of their first sale, appoint a Canadian Responsible Person with a physical Canadian address, and deliver fully bilingual English-French packaging. This guide walks you through each compliance step, from a Korean ISO 22716-certified factory to a Canadian retailer’s shelf.

Canada’s Three-Pillar Cosmetics Regulatory Framework

Canada regulates cosmetics under three overlapping statutes, according to Biorius, a cosmetic regulatory consultancy:

1. Food and Drugs Act — Sets the foundational safety and sanitary production requirements for all cosmetics sold in Canada.
2. Cosmetic Regulations (C.R.C., c. 869) — The primary instrument covering post-market notification, ingredient restrictions, labeling, and manufacturing standards.
3. Consumer Packaging and Labelling Act — Governs bilingual packaging, net-quantity declarations, and packaging transparency across all consumer products.

Canada does not require pre-market approval for cosmetics. There is no license application, no waiting period, and no review queue from Health Canada before a product reaches consumers. The trade-off is that importers carry full responsibility for meeting every requirement before the product ships — Health Canada enforces on the market, not before it.

Product Classification: The Decision That Changes Everything

Before screening a single ingredient or printing a single label, you must confirm your Korean cica serum is classified as a cosmetic in Canada — not a drug or natural health product (NHP).

Per Sourcenutra, the distinction comes down to product claims:

• Cosmetic-safe claims describe appearance effects: “moisturizes skin,” “reduces the visible appearance of fine lines,” “soothes sensitive skin.”
• Drug or NHP-triggering claims imply physiological change: “treats acne,” “stimulates cell regeneration,” “repairs skin barrier function.”

A product reclassified as a drug or NHP must follow a completely different regulatory pathway — one with longer timelines and significantly higher costs. Review every claim on your packaging, your website, and your export documentation before proceeding. This is the single highest-risk decision in the Canadian market entry process.

The Compliance Path from Korean Factory to Canadian Shelf

For a Korean centella serum, six steps make up the complete compliance path. These are not optional steps — they are legal obligations under Canadian law.

Korean Cica Serum: Canada Compliance Path (6 Steps)

1. 1

   Confirm Cosmetic Classification

   Review every marketing claim on packaging and promotional material. Phrases like ‘moisturizes skin’ or ‘soothes sensitive skin’ are cosmetic-safe. Claims like ‘treats acne’ or ‘repairs skin barrier function’ trigger drug or NHP classification — a longer, costlier approval process.

2. 2

   Screen the Health Canada Ingredient Hotlist

   Cross-check every ingredient in the Korean serum formulation against Health Canada’s Cosmetic Ingredient Hotlist (~573 restricted substances). Centella asiatica, niacinamide, and hyaluronic acid are not restricted and are permitted for unrestricted cosmetic use in Canada.

3. 3

   Appoint a Canadian Responsible Person

   Identify a Canadian distributor, importer, or compliance agent with a physical Canadian address. Their name and address must appear on the product label and in the CNF filing. Virtual or foreign-only addresses are not accepted as of March 5, 2025.

4. 4

   File the Cosmetic Notification Form (CNF)

   Submit the CNF to Health Canada within 10 days of the first Canadian sale. Use INCI nomenclature for all ingredients. Classify the product as ‘leave-on’. No pre-approval or waiting period applies — the product can be sold immediately on first offering.

5. 5

   Build Bilingual Labels (English + French)

   All mandatory label elements — product name, function, ingredient list, directions, warnings — must appear in both English and French. INCI ingredient names are the sole exception and do not need translation. Quebec requires French to have equal or greater prominence than English.

6. 6

   Retain Documentation for Six Years

   Keep formulation records, ingredient specifications, and safety documentation for at least six years from the date the product is last sold. Health Canada may request this evidence at any time. Obtain detailed formulation records from the Korean OEM factory at time of order.

Step 1: Confirm Cosmetic Classification

Review all product claims as described above. If any claim implies a physiological effect, revise it before proceeding. Keep a record of all claims reviewed and the decision rationale — this documentation supports your safety substantiation file.

Step 2: Screen the Health Canada Cosmetic Ingredient Hotlist

Health Canada maintains a list of approximately 573 prohibited and restricted cosmetic ingredients, per Cosmeservice. Every ingredient in your Korean serum formulation must be checked against this Hotlist before importation.

For centella serums, the three primary actives — centella asiatica (cica), niacinamide, and hyaluronic acid — are not on the Hotlist and are permitted for unrestricted cosmetic use in Canada, per Cosmeservice. Document this Hotlist screening in your compliance records. Canada’s restricted list is broader than the United States (roughly 30 substances) but significantly narrower than the European Union (over 1,600 substances).

Step 3: Appoint a Canadian Responsible Person

This is the step that catches most first-time Korean exporters off guard. Effective March 5, 2025, Health Canada requires a valid Canadian address in Section 4 of every CNF filing, per Cosmereg. Foreign-only addresses are no longer accepted.

Korean exporters without a Canadian business presence must appoint a Canada-based Responsible Person — a local distributor, importer, or regulatory compliance agent with a physical Canadian address. That person’s name and Canadian address must appear on the product label. Per Biorius, virtual addresses and remote arrangements do not satisfy this requirement.

Step 4: File the Cosmetic Notification Form (CNF)

The CNF is a post-market notification, not a pre-approval. According to Cosmereg, the product can be offered for sale from the first day it is available, with no waiting period from Health Canada. The CNF must be submitted within 10 days of that first sale.

The October 2024 amendment (SOR/2024-63) modernized the CNF format with several new requirements, per Cosmereg:

• Use INCI (International Nomenclature of Cosmetic Ingredients) names for every ingredient. Using trade names is the most common cause of CNF rejection.
• Classify the serum as “leave-on” — this designation determines which fragrance allergen disclosure thresholds apply.
• Provide precise concentration data for all ingredients, not just actives.
• File a separate CNF for each product variant — different sizes, shades, or formulations each require their own notification.

Per Clearit, a licensed Canadian customs broker, no import licence is required for cosmetics. The CNF is the sole regulatory market-entry document.

Bilingual Labeling: The English-French Requirement

All mandatory information on cosmetic labels sold in Canada must appear in both English and French under the Consumer Packaging and Labelling Act, per Clearit. This covers the product name, function description, ingredient list, directions for use, and all warnings.

One important exception: INCI ingredient names do not need to be translated into French. Because most cosmetics already use INCI names internationally, this simplifies bilingual compliance considerably.

Korean exporters targeting Quebec-based retailers or distributors face an additional requirement. Under Quebec’s Charter of the French Language (Bill 96), effective June 1, 2025, French must appear with equal or greater prominence than English on all product labels sold in Quebec, per Biorius. If your Canadian sales reach Quebec, label design must account for this provincial layer on top of the federal bilingual baseline.

Canada Cosmetics Label Compliance Checklist

• ✓ Product name in English and FrenchRequired on the principal display panel
• ✓ Net quantity in metric units (e.g., 30 mL)Declared in both official languages
• ✓ INCI ingredient listINCI names do not need French translation
• ✓ Responsible Person: name and Canadian physical addressMandatory as of March 5, 2025 — no virtual or foreign-only addresses
• ✓ Directions for use in English and FrenchRequired when misuse poses a safety risk
• ✓ Warnings and precautions in English and FrenchInclude all applicable warnings
• ✓ Fragrance allergen declarations (from April 12, 2026)Not required for fragrance-free formulations, but CNF must confirm absence
• ✓ Quebec: French equal or greater prominenceRequired for products sold in Quebec under Bill 96 (effective June 1, 2025)

Fragrance Allergen Rules: What the April 2026 Deadline Means

Starting April 12, 2026, Health Canada mandates individual disclosure of 24 specified fragrance allergens when present above threshold concentrations. For leave-on products like serums, the threshold is above 0.001%, according to CIRS Group. These allergens can no longer be grouped under the collective term “Fragrance (Parfum)” — each must be listed individually by name.

For fragrance-free formulations, no individual allergen listing is required on the label. However, the CNF must explicitly confirm the absence of qualifying allergens. The regulation expands to 81 total allergens for newly introduced products from August 1, 2026, and full compliance for all existing products on the Canadian market is required by August 1, 2028.

Korean exporters should audit their formulations against the 24 initial allergens now and document this review in their CNF and safety records — even if the result is a clean confirmation of zero qualifying allergens.

CKFTA Tariff Benefits: Lower Cost on Every Shipment

The Canada–Korea Free Trade Agreement (CKFTA), in force since January 1, 2015, eliminated tariffs on 97.8% of Canadian tariff lines for Korean goods, per Wikipedia citing Global Affairs Canada. Korean cosmetics under HS Chapter 33, including cica facial serums classified under HS 3304.99, benefit from these preferential rates. Most Korean beauty preparations now enter Canada duty-free under CKFTA.

To claim the preferential treatment, exporters must correctly document the product’s Korean origin on shipping paperwork. CKFTA does not eliminate taxes: a 5% federal Goods and Services Tax (GST), plus applicable provincial sales tax (PST) or Harmonized Sales Tax (HST), still applies on importation, per Clearit. Factor these into your landed-cost calculations.

What to Expect at the Canadian Border

The Canada Border Services Agency (CBSA) may refer cosmetics shipments to Health Canada for regulatory assessment on arrival at the port of entry, per Clearit. Products that do not meet requirements — particularly bilingual labeling and CNF filing status — may be denied entry.

If your first shipment may have labeling gaps, Health Canada’s advance notice of importation process allows importers to declare non-compliant products and arrange remediation — such as re-labeling in a bonded warehouse — before the goods formally enter the Canadian market. Using this process proactively is significantly less expensive than a full shipment refusal.

Korean OEM manufacturers holding ISO 22716 (Cosmetics GMP) certification satisfy the manufacturing standard that aligns closest to Health Canada’s sanitary production requirements, per PCB Trade Services. Canada does not require a formal GMP facility audit for imported cosmetics, but ISO 22716 documentation is accepted as supporting evidence in safety substantiation records and is a recognized quality signal for Canadian buyers evaluating Korean suppliers.

Record Retention: Six Years, No Exceptions

Once you begin selling Korean cosmetics in Canada, Health Canada requires you to retain formulation records, ingredient specifications, and safety documentation for a minimum of six years from the date the product is last sold, per Sourcenutra. The obligation applies to the company marketing the product in Canada — regardless of where the product was manufactured.

Health Canada may request these records in writing at any time. Failure to provide them can result in a product being removed from sale. Korean exporters should collect detailed formulation documentation from the Korean OEM factory at the time of order placement — not after Health Canada asks.

Frequently Asked Questions

Do I need Health Canada approval before I can start selling Korean cica serum in Canada?

No. Canada does not require pre-market approval for cosmetics. The Cosmetic Notification Form (CNF) is a post-market notification, not an application for permission. According to Cosmereg, you may begin selling the product on the first day it is offered, with the CNF filed within 10 business days of that first sale. There is no waiting period and no formal sign-off required from Health Canada before your product goes to market.

What is the Cosmetic Notification Form (CNF), and what information does it require?

The CNF is the sole regulatory market-entry document required for cosmetics in Canada — no import licence is needed, per Clearit. It requires the product name, a complete INCI ingredient list with concentrations, the product category and leave-on/rinse-off classification, the company and Canadian Responsible Person name and address, and confirmation that the formulation has been screened against the Health Canada Ingredient Hotlist. Separate CNFs are required for each product variant. Using trade names instead of INCI nomenclature is the most common reason for CNF rejection.

Do I need to hire a Canadian Responsible Person to import Korean skincare to Canada?

Yes, if you do not have a Canadian business address of your own. As of March 5, 2025, Health Canada requires a valid Canadian address in Section 4 of the CNF, and foreign-only addresses are no longer accepted, per Cosmereg. The Responsible Person’s name and Canadian address must appear on the product label. Their legal responsibility includes ensuring the CNF is filed, that labeling complies with Canadian requirements, and that the six-year documentation retention obligation is met.

Are centella asiatica, niacinamide, and hyaluronic acid on the Health Canada restricted ingredient list?

No. According to Cosmeservice, all three key actives in a standard Korean cica serum formulation — centella asiatica (cica), niacinamide, and hyaluronic acid — are absent from the Health Canada Cosmetic Ingredient Hotlist and are permitted for unrestricted cosmetic use in Canada. The Hotlist currently restricts or prohibits approximately 573 substances. Documenting this Hotlist screening in your safety records is recommended as part of your compliance file.

Can my Korean serum’s label claims in Korea cause problems at the Canadian border?

Yes, they can. Claims that imply a physiological effect — such as “stimulates cell regeneration” or “repairs skin barrier function” — can reclassify a cosmetic as a drug or natural health product in Canada, triggering a more complex regulatory pathway, per Sourcenutra. Review every claim on packaging, marketing materials, and your website before shipping to Canada. Claims that describe visible or sensory effects — “smooths the look of fine lines,” “feels cooling on skin” — remain within the cosmetic classification.

Related Reading

• How to Sell a Korean Centella (Cica) Serum in the USA: FDA MoCRA Registration and Compliance Guide

This article is provided for informational purposes only. Health Canada cosmetics regulations — including Cosmetic Notification Form requirements, ingredient restrictions, bilingual labeling obligations, fragrance allergen disclosure rules, and tariff arrangements under the CKFTA — are subject to change. Always verify current requirements directly with Health Canada or a qualified Canadian regulatory consultant before importing. This information is not legal or regulatory advice.